There are 2789 resources available
Introduction by the chair
Presenter: Pedro Romero
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Bispecific antibodies
Presenter: Roch Houot
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Webcast
CAR T-cells
Presenter: Marcela Maus
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Pedro Romero
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Q&A
Presenter: Pedro Romero
Session: Bispecific antibodies versus CAR T cells: Which one prevails?
Resources:
Slides
Webcast
Identifying bias: Top tips when reading a paper
Presenter: Dario Trapani
Session: ESMO-MCBS: Can we keep it free from bias?
Resources:
Slides
Webcast
ESMO-MCBS and quality of life: What is the impact on understanding value?
Presenter: Sjoukje Oosting
Session: ESMO-MCBS: Can we keep it free from bias?
Resources:
Slides
Webcast
ESMO-MCBS version 2: What is new and why?
Presenter: Nathan Cherny
Session: ESMO-MCBS: Can we keep it free from bias?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Nathan Cherny
Session: ESMO-MCBS: Can we keep it free from bias?
Resources:
Slides
LBA60 - Prospective data of >20,000 hospitalised patients with cancer and COVID-19 derived from the International Severe Acute Respiratory and emerging Infections Consortium WHO Coronavirus Clinical Characterisation Consortium: CCP-CANCER UK
Presenter: Tom Drake
Session: Mini oral session - SARS-CoV-2 and cancer
Resources:
Abstract
Slides
Webcast